Trajectories of opioid prescribing by general dentists, specialists, and oral and maxillofacial surgeons in the United States, 2015-2019

• Published in: The Journal of the American Dental Association (1939) Vol. 155; no. 1; pp. 7 - 16.e7
• Main Authors: Khouja, Tumader, Shah, Nilesh H., Suda, Katie J., Polk, Deborah E.
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.01.2024
• Subjects: Analgesic; Analgesics, Opioid - therapeutic use; dentists; Humans; opioid; Oral and Maxillofacial Surgeons; practice patterns; Practice Patterns, Dentists; Practice Patterns, Physicians; prescriptions; United States; United States; CE; CDC; Q1-Q3; dentists; MME; NSAID; opioid; OMFS; practice patterns; PDMP; Analgesic; LRx; GBTM; prescriptions
• ISSN: 0002-8177; 1943-4723
• DOI: 10.1016/j.adaj.2023.10.002

Despite decreases in opioid prescribing from 2016 through 2019, some dentists (general, specialists, oral and maxillofacial surgeons) in the United States continue to prescribe opioids at high rates. The authors’ objective was to define dentists’ trajectories of opioid prescribing. The authors identified actively prescribing dentists from the IQVIA Longitudinal Prescription data set, from 2015 through 2019. Group-based trajectory modeling identified opioid prescribing trajectories on the basis of dentists’ annual prescribing rates for the overall sample (model 1) and for high prescribers (model 2). The authors used χ2 or Mann-Whitney U tests to characterize the model 2 trajectory groups. In model 1 (n = 199,145 prescribers), group-based trajectory modeling identified 8 trajectories that were grouped into 5 categories. A total of 14.8% were nonprescribers who composed less than 1% of all prescriptions, low prescribers (3 groups; 46.0%) prescribed at low rates (2015: 5.5%-16.9%; 2019: 1.5%-11.9%), decliners (7.3%) decreased prescribing rapidly (2015: 29.4%; 2019: 5.1%), moderately high prescribers (2 groups; 28.5%) prescribed moderately (2015: 28.7% and 39.2%; 2019: 18.1% and 28.8%), and consistently high prescribers (3.4%) prescribed at high rates (2015: 54.6%; 2019: 44.7%). In model 2, from consistently high prescribers (n = 6,845), 4 trajectories were identified. Of these 4 groups, 1 group (7.5%) declined prescribing rapidly. The groups did not differ meaningfully; however, the rapid decliners included fewer oral and maxillofacial surgeons (13.0% vs 18.4%), saw more Medicaid patients (2.5% vs 1.0%), and had higher opioid prescribing rates in 2015 (95.5% vs 91.6%) (P < .001 for all). The authors identified variations in dentists’ opioid prescribing rates. Although 60% of dentists decreased prescribing rates by 30% through 83%, 3.4% of dentists consistently prescribed at high rates. Some dentists continue to prescribe opioids at high levels, indicating that additional information is needed to better inform policy and clinical decision making.